Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)-resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2009
|
| 在线阅读: | https://doi.org/10.1002/hep.23145 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.23145 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|